Ultimately, six CARMRs (ALYREF, DNMT1, DNMT3B, EXO1, HNRNPA2B1, TRDMT1) were included in our analysis to establish a prognostic model for estimating the risk of PCa recurrence. Here, HNRNPA2B1 is linked to posterior cortical atrophy.